Home    Back

Dietary therapy    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease3

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 2,209 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03266484
(ClinicalTrials.gov)		November 13, 201725/8/2017Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseEffect of Dietary Therapy With a Probiotic Mixture on the Gut Microbiome and Fatigue Symptoms in Patients With Quiescent Inflammatory Bowel Disease - A Clinical TrialInflammatory Bowel Diseases;Crohn Disease;Ulcerative ColitisDietary Supplement: Probiotic Mixture;Dietary Supplement: PlaceboMassachusetts General HospitalWinclove Bio Industries BVRecruiting18 Years75 YearsAll100N/AUnited States
2NCT02231814
(ClinicalTrials.gov)		December 201627/8/2014Pilot Study of Partial Enteral Nutrition With a Unique Diet for the Treatment of Adult Patients With Crohn's DiseaseDietary Therapy Using Partial Enteral Nutrition and the Crohn's Disease Exclusion Diet (CDED) for Induction and Maintenance of Remission in Mild to Moderate Crohn's Disease in Adults- A Pilot StudyCrohn's DiseaseDietary Supplement: Crohns Disease Exclusion Diet + PEN;Other: Crohns Disease Exclusion DietProf. Arie LevineNULLRecruiting18 Years55 YearsAll40N/AIsrael
3NCT00343642
(ClinicalTrials.gov)		September 200621/6/2006Dietary Treatment of Crohn's DiseaseDietary Treatment of Crohn's DiseaseCrohn's Disease;Inflammatory Bowel DiseaseDietary Supplement: Time and attention + fructo-oligosaccharide placebo;Dietary Supplement: dietary therapy + fructo-oligosaccharide placebo;Drug: Time and attention + active fructooligosaccharide supplementationRush University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Completed18 Years80 YearsBoth73Phase 1;Phase 2United States